Physician profile
Cedric J Strong
NPI 1881600930
$1,180.48
in general payments reported to CMS, 2019-2025
12 companies · $27.23 in 2025
The $27.23 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.20 · 2020: $18.68 · 2022: $36.19 · 2023: $783 · 2024: $259 · 2025: $27.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973 · Education: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.60 |
| Education | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $245.82 | 2022-2023 | Perseris |
| Abbvie INC. | $232.60 | 2023-2024 | Ubrelvy, Dalvance, Qulipta |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $149.83 | 2023 | |
| Novo Nordisk INC | $134.75 | 2023 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $98.91 | 2023-2024 | Xarelto |
| Philips North America LLC | $59.52 | 2024 | (Ck7) Extended Holter, (Ck6) Holter |
| Otsuka America Pharmaceutical, INC. | $57.19 | 2024-2025 | Abilify Asimtufii, Abilify Maintena |
| Pfizer INC. | $56.20 | 2019 | |
| Irhythm Technologies, INC. | $53.08 | 2023-2024 | Zio Xt Patch |
| Boston Scientific Corporation | $48.32 | 2023 | Bodyguardian |
| Medtronic, INC. | $25.58 | 2024 | Minimed 780g |
| Allergan, INC. | $18.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cedric Strong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.